Lattuada Debora, Somigliana Edgardo, Viganò Paola, Candiani Massimo, Pardi Giorgio, Di Blasio Anna Maria
Molecular Biology Laboratory, Istituto Auxologico Italiano, University of Milan, Milan, Italy.
Clin Endocrinol (Oxf). 2004 Aug;61(2):190-4. doi: 10.1111/j.1365-2265.2004.02076.x.
Endometriosis is a steroid-dependent disease with a particular genetic background, but the locations of possible genomic aberrations are still poorly clarified. We have investigated the potential association between endometriosis and the PROGINS 306 base pair insertion polymorphism in intron G of the progesterone receptor (PR) gene, which has been reported previously to segregate with this disease.
In a case-control study, we examined the PROGINS polymorphism of the progesterone receptor gene in 131 Italian women affected by endometriosis diagnosed according to published criteria for the definition of the definite disease. Control subjects were represented by 127 Italian women without laparoscopic evidence of the disease.
Peripheral blood samples, DNA extraction and polymerase chain reaction (PCR) were used to genotype women for the presence of the PROGINS polymorphism.
We found a statistically significant difference in the distribution of PROGINS genotypes between patients with and without endometriosis. The frequency of the PROGINS allele T2 was 17.2% and 11%, respectively, in affected women and in controls [odds ratio (OR) = 1.7, 95% confidence interval (CI) 1.0-2.8]. This association was stronger in patients with more severe forms of endometriosis, such as an infiltrating disease or a disease characterized by severe pelvic adhesions (OR 2.4, 95% CI 1.2-4.8; and OR 2.7, 95% CI 1.4-5.3, respectively). Combination of the results from an earlier study and the current data indicates that carrying the allele variant T2 is associated with a twofold increase in the risk of developing endometriosis (OR 2.0, 95% CI 1.3-2.9).
Our results further support the idea that the PROGINS polymorphism of the progesterone receptor may be associated with an increased risk of endometriosis.
子宫内膜异位症是一种具有特定遗传背景的类固醇依赖性疾病,但可能的基因组畸变位置仍不清楚。我们研究了子宫内膜异位症与孕激素受体(PR)基因内含子G中PROGINS 306碱基对插入多态性之间的潜在关联,此前已有报道称该多态性与这种疾病相关。
在一项病例对照研究中,我们检测了131名根据已发表的明确疾病定义标准诊断为子宫内膜异位症的意大利女性孕激素受体基因的PROGINS多态性。对照受试者为127名无腹腔镜疾病证据的意大利女性。
采用外周血样本、DNA提取和聚合酶链反应(PCR)对女性进行PROGINS多态性基因分型。
我们发现有和没有子宫内膜异位症的患者之间PROGINS基因型分布存在统计学显著差异。在受影响女性和对照组中,PROGINS等位基因T2的频率分别为17.2%和11%[优势比(OR)=1.7,95%置信区间(CI)1.0 - 2.8]。这种关联在子宫内膜异位症更严重形式的患者中更强,如浸润性疾病或伴有严重盆腔粘连的疾病(分别为OR 2.4,95% CI 1.2 - 4.8;以及OR 2.7,95% CI 1.4 - 5.3)。早期研究结果与当前数据相结合表明,携带等位基因变体T2会使患子宫内膜异位症的风险增加两倍(OR 2. ADP转化为ATP,而NADPH则是由光反应中产生的电子和质子还原NADP⁺形成的。在暗反应中,ATP和NADPH为二氧化碳的固定和还原提供能量和还原力,使二氧化碳转化为碳水化合物。
我们的结果进一步支持了孕激素受体的PROGINS多态性可能与子宫内膜异位症风险增加相关的观点。 0,95% CI 1.3 - 2.9)。
我们的结果进一步支持了孕激素受体的PROGINS多态性可能与子宫内膜异位症风险增加相关的观点。